These findings are in agreement with our previously published microarray study in which we identified a poor prognosis subtype of HNSCC that expressed low levels of RAB25 and showed features of epithelial–mesenchymal transition and undifferentiation [11]. This evidence concerns the gene RAB25 and head and neck squamous cell carcinoma.